Hantavirus Infections

Tropical Infectious Diseases

Volumn 1, Issue , 2006, Pages 762-780

  Peters, C J ^a   Mills, James N ^b   Spiropoulou, Christina ^c   Zaki, Sherif R ^d   Rollin, Pierre E ^d  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882542975     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06668-9.50073-9     Document Type: Chapter

References (211)

1. Lee H, Lee P Korean hemorrhagic fever. 1. Demonstration of the causative antigen and antibodies. Korean J Intern Med 1976, 19:371.
2. Lee HW, Johnson KM Isolation of the etiologic agent of Korean Hemorrhagic fever. J Infect Dis 1978, 137:298-308.
3. Schmaljohn CS, Hasty SE, Harrison SA, et al. Characterization of Hantaan virions, the prototype virus of hemorrhagic fever with renal syndrome. J Infect Dis 1983, 148:1005-1012.
4. Schmaljohn CS, Hasty SE, Dalrymple JM, et al. Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science 1985, 227:1041-1044.
5. Nichol ST, Spiropoulou CF, Morzunov S, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. [Comment]. Science 1993, 262:914-917.
6. Carey DE, Reuben R, Panicker KN, et al. Thottapalayam virus: A presumptive arbovirus isolated from a shrew in India. Indian J Med Res 1971, 59:1758-1760.
7. White JD, Shirey FG, French GR, et al. Hantaan virus, aetiological agent of Korean haemorrhagic fever, has Bunyaviridae-like morphology. Lancet 1982, 1:768-771.
8. Goldsmith CS, Eliott LH, Peters CJ, et al. Ultrastructural characteristics of Sin Nombre virus, causative agent of hantavirus pulmonary syndrome. Arch Virol 1995, 140:2107-2122.
9. Schmaljohn CS, Hooper JW Bunyaviridae: The viruses and their replication. Fields Virology 2001, 1581-1602. Lippincott-Raven, Philadelphia. 4th ed. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
10. Spiropoulou CF, Morzunov S, Feldmann H, et al. Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology 1994, 200:715-723.
11. Gavrilovskaya IN, Shepley M, Shaw R, et al. Beta3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Nat Acad Sci USA 1998, 95:7074-7079.
12. Garcin D, Lezzi M, Dobbs SM, et al. The 5' ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. J Virol 1995, 69:5754-5762.
13. Hutchinson KL, Peters CJ, Nichol ST Sin Nombre virus mRNA synthesis. Virology 1996, 224:139-149.
14. Chizhikov VE, Spiropoulou CF, Morzunov SP, et al. Complete genetic characterization and analysis of isolation of Sin Nombre virus. J Virol 1995, 69:8132-8136.
15. Flick K, Hooper J, Schmaljohn C, et al. Rescue of Hantaan virus minigenomes. Virology 2003, 306:219-224.
16. Spiropoulou CF Hantavirus maturation. Hantaviruses, Current Topics in Microbiology and Immunology 2001, 33-46. Springer-Verlag, New York. C.S. Schmaljohn, S.T. Nichol (Eds.).
17. Ravkov EV, Nichol ST, Peters CJ, et al. Role of actin microfilaments in Black Creek Canal virus morphogenesis. J Virol 1998, 72:2865-2870.
18. Spiropoulou CF, Goldsmith C, Showmaker T, et al. Sin Nombre glycoprotein trafficking. Virology 2003, 308:48-63.
19. Ravkov EV, Nichol ST, Peters CJ, et al. Role of actin microfilaments in Black Creek Canal virus morphogenesis. J Virol 1998, 72:2865-2870.
20. Rodriguez LL, Owens JH, Peters CJ, et al. Genetic reassortment among viruses causing hantavirus pulmonary syndrome. Virology 1998, 242:99-106.
21. Plyusnin A, Kukkonen SKJ, Plyusnina A, et al. Transfection-mediated generation of functionally competent Tula hantavirus with recombinant S RNA segment. EMBO J 2002, 21:1497-1503.
22. Nichol ST Bunyavirdae. Fields Virology 2001, 1603-1633. Lippincott-Raven, Philadelphia. 4th ed. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
23. Lee HW, French GR, Lee PW, et al. Observations on natural and laboratory infection of rodents with the etiologic agent of Korean hemorrhagic fever. Am J Trop Med Hyg 1981, 30:477-482.
24. Hooper JW, Larsen T, Custer DM, et al. A lethal disease model for hantavirus pulmonary syndrome. Virology 2001, 289:6-14.
25. Milazzo ML, Eyzaquirre EJ, Molina CP, et al. Maporal viral infection in the Syrian golden hamster: A model of hantavirus pulmonary syndrome. J Infect Dis 2002, 186:1390-1395.
26. French GR, Foulke RS, Brand OA, et al. Korean hemorrhagic fever: Propagation of the etiologic agent in a cell line of human origin. Science 1981, 211:1046-1048.
27. Gavrilovskaya IN, Chumakov MP, Apekina NS, et al. Adaptation to laboratory and wild animals of the haemorrhagic fever with renal syndrome virus present in the foci of European USSR: Brief report. Arch Virol 1983, 77:87-90.
28. Elliott LH, Ksiazek TG, Rollin PE, et al. Isolation of the causative agent of hantavirus pulmonary syndrome. Am J Trop Med Hyg 1994, 51:102-108.
29. Nemirov K, Lundkvist A, Vaheri A, et al. Adaptation of Puumala hantavirus to cell culture is associated with point mutations in the coding region of the L segment and in the noncoding regions of the S segment. J Virol 2003, 77:8793-8800.
30. Lee HW Korean hemorrhagic fever. Prog Med Virol 1982, 28:96-113.
31. Galeno H, Mora J, Villagra E, et al. First human isolate of hantavirus (Andes virus) in the Americas. Emerg Infect Dis 2002, 8:657-661.
32. Temonen M, Vapalahti O, Holthofer H, et al. Susceptibility of human cells to Puumala virus infection. J Gen Virol 1993, 74:515-518.
33. Nolte KB, Feddersen RM, Foucar K, et al. Hantavirus pulmonary syndrome in the United States: A pathological description of a disease caused by a new agent. Hum Pathol 1995, 26:110-120.
34. Zaki SR, Greer PW, Coffield LM, et al. Hantavirus pulmonary syndrome: Pathogenesis of an emerging infectious disease. Am J Pathol 1995, 146:552-579.
35. Yanagihara R, Silverman DJ Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch Virol 1990, 111:281-286.
36. Sundstrom JB, McMullan LK, Spiropoulou CF, et al. Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J Virol 2001, 75:6070-6085.
37. Traub R, Wisseman CL Korean hemorrhagic fever. J Infect Dis 1978, 138:267-272.
38. Lee HW, Lee PW, Baek LJ, et al. Intraspecific transmission of Hantaan virus, etiologic agent of Korean hemorrhagic fever, in the rodent Apodemus agrarius. Am J Trop Med Hyg 1981, 30:1106-1112.
39. Peters CJ, Zaki SR, Rollin PE Viral hemorrhagic fevers. Atlas of Infectious Diseases. External Manifestations of Systemic Infections 1997, 8. Churchill Livingstone, Philadelphia. G.L. Mandell, R. Fekety (Eds.).
40. Mills JN, Ksiazek TG, Ellis BA, et al. Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg 1997, 56:273-284.
41. Dohmae K, Koshimizu U, Nishimune Y In utero and mammary transfer of hantavirus antibody from dams to infant rats. Lab Anim Sci 1993, 43:557-561.
42. Glass GE, Childs JE, Korch GW, et al. Association of intraspecific wounding with hantaviral infection in wild rats ( Rattus norvegicus). Epidemiol Infect 1988, 101:459-472.
43. Douglass RJ, Wilson T, Semmens WJ, et al. Longitudinal studies of Sin Nombre virus in deer mouse dominated ecosystems of Montana. Am J Trop Med Hug 2001, 65:33-41.
44. Glass GE, Livingstone W, Mills JN, et al. Black Creek Canal virus infection in Sigmodon hispidus in Southern Florida. Am J Trop Med Hyg 1999, 59:699-703.
45. Childs JE, Korch GW, Smith GA, et al. Geographical distribution and age related prevalence of antibody to Hantaan-like virus in rat populations of Baltimore, Maryland, USA. Am J Trop Med Hyg 1985, 34:385-387.
46. Niklasson B, Hornfeldt B, Lundkvist A, et al. Temporal dynamics of Puumala virus antibody prevalence in voles and of nephropathia epidemica incidence in humans. Am J Trop Med Hyg 1995, 53:134-140.
47. Escutenaire P, Chalon R, Verhagen P, et al. Spatial and temporal dynamics of Puumala hantavirus infection in red bank vole ( Clethrionomys glareolus) populations in Belgium. Virus Res 2000, 67:91-107.
48. Nuzum EO, Rossi CA, Stephenson EH, et al. Aerosol transmission of Hantaan and related viruses to laboratory rats. Am J Trop Med Hyg 1988, 38:636-640.
49. Krebs DJ, Myers JH Population cycles in small mammals. Adv Ecol Res 1974, 8:267-399.
50. Hornfeldt B Delayed density dependence as a determinant of vole cycles. Ecology 1994, 75:791-806.
51. Hantavirus pulmonary syndrome-Colorado and New Mexico, 1998. MMWR 1998, 47:449-452. Centers for Disease Control and Prevention.
52. Update: hantavirus pulmonary syndrome-United States, 1999. MMWR 1999, 48:521-525. Centers for Disease Control and Prevention.
53. Toro J, Vega JD, Khan AS, Navarrete M, et al. An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infec Dis 1998, 4:687-694.
54. Marua R, Gonzales LE, Navarrete M, et al. Efectos del florecimiento del arbusto Chusquea quila Kunth (Poaceae) sobre la demografia de poblaciones de roedores de los bosques templados frios del sur Chileno. Bol Soc Biol (Conception, Chile) 1996, 67:37.
55. Mills JN, Ksiazek TG, Peters CJ, et al. Long-term studies of hantavirus reservoir populations in the southwestern United States: A synthesis. Emerg Infect Dis 1999, 5:135-142.
56. Yates TL, Mills JN, Parmenter RR, et al. The ecology and evolutionary history of an emergent disease: Hantavirus pulmonary syndrome. Bioscience 2002, 52:989-998.
57. Bayard V, Kitsutani PT, Barria EO, et al. Outbreak of hantavirus pulmonary syndrome, Los Santos Panama, 1999-2000. Emerg Infect Dis 2004, 10:1635-1642.
58. Carroll DS, Mills JN, Montgomery JM, et al. Hantavirus pulmonary syndrome in central Bolivia: Relationships between reservoir hosts, habitats, and viral genotypes. Am J Trop Med Hyg 2005, 72:42-46.
59. Zeitz PS, Butler JC, Cheek JE, et al. A case-control study of hantavirus pulmonary syndrome during an outbreak in the southwestern United States. [See comment]. J Infect Dis 1995, 171:864-870.
60. Ahlm C, Juto P, Stegmayr B, et al. Prevalence of serum antibodies to hantaviruses in northern Sweden as measured by recombinant nucleocapsid proteins. Scand J Infect Dis 1997, 29:349-354.
61. Childs JE, Ksiazek TG, Spiropoulou C, et al. Serologic and genetic identification of Peromyscus maniculatus as the primary rodent reservoir for a new hantavirus in the southwestern United States. J Infect Dis 1994, 169:1271-1280.
62. Rowe JE, St Jeor SC, Riolo J, et al. Coexistence of several novel hantaviruses in rodents indigenous to North America. Virology 1995, 213:122-130.
63. Nowotny N, Weissenboeck H, Aberle S, et al. Hantavirus infection in the domestic cat. JAMA 1994, 272:1100-1101.
64. Xu ZY, Guo CS, Wu YL, et al. Epidemiological studies of hemorrhagic fever with renal syndrome: Analysis of risk factors and mode of transmission. J Infect Dis 1985, 152:137-144.
65. Tsai TF Hemorrhagic fever with renal syndrome: mode of transmission to humans. Lab Anim Sci 1987, 37:428-430.
66. Yanagihara R Hantavirus infection in the United States: Epizootiology and epidemiology. Rev Infect Dis 1990, 12:449-457.
67. Dixon KE A comparison of case-crossover and case-control designs in a study of risk factors for hemorrhagic fever with renal syndrome. Epidemiology 1997, 8:243-246.
68. Dournon E, Moriniere B, Girard P, et al. HFRS after a wild rodent bite in the Haute-Savoie and risk of exposure to Hantaan-like virus in a Paris laboratory. Lancet 1984, 1:676-677.
69. Kawamata J, Yamanouchi T, Dohmae K, et al. Control of laboratory acquired hemorrhagic fever with renal syndrome (HFRS) in Japan. Lab Anim Sci 1987, 37:431-436.
70. Dimmick RL, Vogl WF, Schmidt L, et al. Potential for accidental microbial aerosol transmission in the biological laboratory. Biohazards in Biological Research 1973, 246. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. A. Hellman, M.N. Oxman, R. Pollack (Eds.).
71. Yanagihara R, Amyx HL, Gajdusek DC, et al. Experimental infection with Puumala virus, the etiologic agent of nephropathia epidemica, in bank voles ( Clethrionomys glareolus). J Virol 1985, 55:34-38.
72. Gavrilovskaya IN, Apekina NS, Myasnikova YA, et al. Pathogenesis of hemorrhagic fever with renal syndrome virus infection and mode of horizontal transmission of hantavirus in bank voles. Arch Virol 1990, (suppl 1):57-62.
73. Hutchinson KL, Rollin PE, Peters CJ Pathogenesis of a North American hantavirus, Black Creek Canal virus, in experimentally infected Sigmodon hispidus. Am J Trop Med Hyg 1998, 59:58-65.
74. Antoniadis A, Stylianakis A, Papa A, et al. Direct genetic detection of Dobrava virus in Greek and Albanian patients with hemorrhagic fever with renal syndrome. [See comment]. J Infect Dis 1996, 174:407-410.
75. LeDuc JW, Smith GA, Childs JE, et al. Global survey of antibody to Hantaan-related viruses among peridomestic rodents. Bull World Health Organ 1986, 64:139-144.
76. Lee HW, Baek LJ, Johnson KM Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats. J Infect Dis 1982, 146:638-644.
77. Park SC, Pyo HJ, Joe JB, et al. A clinical study of hemorrhagic fever with renal syndrome caused by Seoul virus infection. Korean J Intern Med 1989, 4:130-135.
78. Chen HX, Qiu FX, Dong BJ, et al. Epidemiological studies on hemorrhagic fever with renal syndrome in China. J Infect Dis 1986, 154:394-398.
79. Li YL, Ruo SL, Tong Z, et al. A serotypic study of hemorrhagic fever with renal syndrome in rural China. Am J Trop Med Hyg 1995, 52:247-251.
80. Glass GE, Watson AJ, LeDuc JW, et al. Domestic cases of hemorrhagic fever with renal syndrome in the United States. Nephron 1994, 68:48-51.
81. Glass GE, Watson AJ, LeDuc JW, et al. Infection with a ratborne hantavirus in US residents is consistently associated with hypertensive renal disease. J Infect Dis 1993, 167:614-620.
82. Kariwa H, Isegawa Y, Arikawa J, et al. Comparison of nucleotide sequences of M genome segments among Seoul virus strains isolated from eastern Asia. Virus Res 1994, 33:27-38.
83. LeDuc JW Epidemiology of Hantaan and related viruses. Lab Anim Sci 1987, 37:413-418.
84. LeDuc JW, Smith GA, Macy M, et al. Certified cell lines of rat origin appear free of infection with hantavirus. J Infect Dis 1985, 152:1082-1083.
85. McKenna P, van der Groen G, Hoofd G, et al. Eradication of hantavirus among laboratory rats by application of caesarian section and a foster mother technique. J Infect 1992, 25:181-190.
86. Avsic-Zupanc T, Poljak M, Furlan P, et al. Isolation of a strain of a Hantaan virus from a fatal case of hemorrhagic fever with renal syndrome in Slovenia. Am J Trop Med Hyg 1994, 51:393-400.
87. Antoniadis A, Stylianakis A, Papa A, et al. Direct genetic detection of Dobrava virus in Greek and Albanian patients with hemorrhagic fever with renal syndrome. [See comment]. J Infect Dis 1996, 174:407-410.
88. Lokugamage K, Karjwa H, Hayasaka D, et al. Genetic characterization of hantaviruses transmitted by the Korean field mouse ( Apodemus peninsulae), far east Russia. Emerg Infect Dis 2002, 8:768-776.
89. Chu YK, Rossi C, LeDuc JW, et al. Serological relationships among viruses in the Hantavirus genus, family Bunyaviridae. Virology 1994, 198:196-204.
90. Xiao SY, Leduc JW, Chu YK, et al. Phylogenetic analyses of virus isolates in the genus Hantavirus, family Bunyaviridae. Virology 1994, 198:205-217.
91. Mills JN, Ellis BA, McKee KT, et al. A longitudinal study of Junin virus activity in the rodent reservoir of Argentine hemorrhagic fever. Am J Trop Med Hyg 1992, 47:749-763.
92. Levis S, Morzunov SP, Rowe JC, et al. Genetic diversity and epidemiology of hantaviruses in Argentina. J Infect Dis 1988, 177:529-538.
93. Williams RJ, Bryan RT, Mills JN, et al. An outbreak of hantavirus pulmonary syndrome in western Paraguay. Am J Trop Med Hyg 1997, 57:274-282.
94. Mills JN, Childs JE Ecologic studies of rodent reservoirs: their relevance for human health. Emerg Infect Dis 1998, 4:529-537.
95. Gauld RL, Craig JP Epidemiological pattern of localized outbreaks of epidemic hemorrhagic fever. Am J Hyg 1954, 59:32-38.
96. Smorodinstev AA, Chudokov VG, et al. Hemorrhagic Nephrosonephritis 1959, Pergamon Press, New York. A.A. Smorodinstev, V.G. Chudakov, A.V. Churilov (Eds.).
97. Korpela H, Lahdevirta J The role of small rodents and patterns of living in the epidemiology of nephropathia epidemica. Scand J Infect Dis 1978, 10:303-305.
98. Dixon KE, Nang RN, Kim DY, et al. A hospital-based, case-control study of risk factors for hemorrhagic fever with renal syndrome in soldiers of the armed forces of the Republic of Korea. Am J Trop Med Hyg 1996, 54:284-288.
99. Nowotny N The domestic cat: A possible transmitter of viruses from rodents to man. [Comment]. Lancet 1994, 343:921.
100. Childs JE, Krebs JW, Ksiazek T, et al. A household-based, case-control study of environmental factors associated with hantavirus pulmonary syndrome in the southwestern United States. Am J Trop Med Hyg 1995, 52:393-397.
101. Armstrong LR, Zaki SR, Goldoft MJ, et al. Hantavirus pulmonary syndrome associated with entering or cleaning rarely used, rodent-infested structures. [Comment]. J Infect Dis 1995, 172:1166.
102. Kuenzi AJ, Douglass RJ, White D, et al. Antibody to Sin Nombre virus in rodents associated with peridomestic habitats in west central Montana. Am J Trop Med Hyg 2001, 63:137-146.
103. Kim S, Kim W, Yoon HJ, et al. Changing patterns of epidemiology and death causes on epidemic hemorrhagic fever in Korea. Korean J Infect Dis 1976, 8:58.
104. Andrew R Epidemic haemorrhagic fever: 40 cases from Korea. BMJ 1953, 1:1063-1068.
105. Ganong WF, Zucker E, Clawson CK, et al. The early field diagnosis of epidemic hemorrhagic fever. Ann Intern Med 1953, 38:61-66.
106. Earle DP Analysis of sequential physiologic derangements in epidemic hemorrhagic fever; with a commentary on management. Am J Med 1954, 16:690-709.
107. Powell GM Hemorrhagic fever: a study of 300 cases. Medicine (Baltimore) 1954, 33:97-153.
108. Sheedy JA, Froeb HF, Batson HA, et al. The clinical course of epidemic hemorrhagic fever. Am J Med 1954, 16:619-628.
109. Lee JG, Cho B, Lee MC, et al. Clinical features of serologically proven Korean hemorrhagic fever patients. Seoul J Med 1980, 21:163.
110. Bruno P, Hassell LH, Quan J, et al. The protean manifestations of hemorrhagic fever with renal syndrome: A retrospective review of 26 cases from Korea. Ann Intern Med 1990, 113:385-391.
111. Lee M, Kim BK, Kim S, et al. Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever). Rev Infect Dis 1989, 11(suppl 4):S877-S883.
112. Zaki SR Hantavirus-associated diseases. The Pathology of Infectious Diseases 1997, 125. Appleton & Lange, Norwalk, CT. D.H. Connor, F.W. Chandler, D.A. Schwartz (Eds.).
113. Sirotin BZ, Obukhova GG, Mogila TV [Kallikrein-kinin, coagulative and fibrinolytic blood systems in patients with hemorrhagic fever and renal syndrome]. Terapevticheskii Arkhiv 1981, 53:84-87.
114. Entwisle G, Hale E Hemodynamic alterations in hemorrhagic fever. Circulation 1957, 15:414-425.
115. Smyth AG, Powell GM The electrocardiogram in hemorrhagic fever. Am Heart J 1954, 47:218-240.
116. Koh C, Kim W, Lee JS, et al. Clinical study of Korean hemorrhagic fever. Korean J Med 1972, 15:757.
117. Chun PK, Godfrey LJ Unique selective right atrial hemorrhage with epidemic (Korean) hemorrhagic fever. Am Heart J 1984, 108:410-412.
118. Kim YS, Lee JS, Ahn C, et al. Magnetic resonance imaging of the kidney in hemorrhagic fever with renal syndrome: its histopathologic correlation. Nephron 1997, 76:477-480.
119. Hullinghorst RL, Steer A Pathology of epidemic hemorrhagic fever. Ann Intern Med 1953, 38:77-101.
120. Valiakhmetov RZ, Gafarov AI, Memkhes VS, et al. [Spontaneous rupture of the kidneys in hemorrhagic fever with renal syndrome]. Urol Nefrol 1990, 6:50-53.
121. Lee JG, Han JS, Kim S, et al. Panhypopituitarism in the acute stage of hemorrhagic fever with renal syndrome: A case report. Arch Virol 1990, (suppl 1):95.
122. Desmyter J, LeDuc JW, Johnson KM, et al. Laboratory rat associated outbreak of haemorrhagic fever with renal syndrome due to Hantaan-like virus in Belgium. Lancet 1983, 2:1445-1448.
123. Lloyd G, Bowen ET, Jones N, et al. HFRS outbreak associated with laboratory rats in UK. Lancet 1984, 1:1175-1176.
124. Lahdevirta J Nephropathia epidemica in Finland: A clinical histological and epidemiological study. Ann Clin Res 1971, 3:1-54.
125. Niklasson B, Hornfeldt B, Mullart M, et al. An epidemiologic study of hemorrhagic fever with renal syndrome in Bashkirtostan (Russia) and Sweden. Am J Trop Med Hyg 1993, 8:670-675.
126. Mustonen J, Brummer-Korvenkontio M, Hedman K, et al. Nephropathia epidemica in Finland: A retrospective study of 126 cases. Scand J Infect Dis 1994, 26:7-13.
127. Rollin PE, Coudrier D, Sureau P, et al. Hantavirus epidemic in Europe, 1993. [See comment]. Lancet 1994, 343:115-116.
128. Colson P, Damoiseaux P, Brisbois J, et al. [Epidemic of hantavirus disease in Entre-Sambre-et-Meuse, 1992-1993: Clinical and biological aspects]. Acta Clin Belg 1995, 50:197-206.
129. Kontkanen MI, Puustjarvi TJ, Lahdevirta JK, et al. Intraocular pressure changes in nephropathia epidemica: A prospective study of 37 patients with acute systemic Puumala virus infection. Ophthalmology 1995, 102:1813-1817.
130. Kleinknecht D, Rollin PE Hypertension after hemorrhagic fever with renal syndrome. Nephron 1992, 61:121.
131. Niklasson B, Hellsten G, LeDuc JW Hemorrhagic fever with renal syndrome: A study of sequelae following nephropathia epidemica. Arch Virol 1994, 137:241-247.
132. Niklasson B, LeDuc J, Nystrom K, et al. Nephropathia epidemica: Incidence of clinical cases and antibody prevalence in an endemic area of Sweden. Epidemiol Infect 1987, 99:559-562.
133. Niklasson B, Jonsson M, Lundkvist A, et al. Comparison of European isolates of viruses causing hemorrhagic fever with renal syndrome by a neutralization test. Am J Trop Med Hyg 1991, 45:660-665.
134. Alexeyev OA, Baranov BA Puumala virus infection without signs of renal involvement. Scand J Infect Dis 1993, 25:525-527.
135. Alexeyev OA, Morozov VG, Efremor AG, et al. A case of haemorrhagic fever with renal syndrome complicated by spleen haemorrhage. Scand J Infect Dis 1994, 26:491-492.
136. Chan KP, Chan YC, Doraisingham S A severe case of hemorrhagic fever with renal syndrome in Singapore. Southeast Asian J Trop Med Public Health 1996, 27:408-410.
137. Meng G, Lan Y, Nakagawa M, et al. High prevalence of hantavirus infection in a group of Chinese patients with acute hepatitis of unknown aetiology. J Viral Hepat 1997, 4:231-234.
138. Duchin JS, Koster FT, Peters CJ, et al. Hantavirus pulmonary syndrome: A clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. [See comment]. N Engl J Med 1994, 330:949-955.
139. Ksiazek TG, Peters CJ, Rollin PE, et al. Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg 1995, 52:117-123.
140. Ketai LH, Williamson MR, Telepak RJ, et al. Hantavirus pulmonary syndrome: Radiographic findings in 16 patients. Radiology 1994, 191:665-668.
141. Moolenaar RL, Dalton C, Lipman HB, et al. Clinical features that differentiate hantavirus pulmonary syndrome from three other acute respiratory illnesses. Clin Infect Dis 1995, 21:643-649.
142. Hallin GW, Simpson SQ, Crowell RE, et al. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 1996, 24:252-258.
143. Khan AS, Ksiazek TG, Peters CJ Hantavirus pulmonary syndrome. Lancet 1996, 347:739-741.
144. Levy H Hantavirus infection. Curr Opin Infect Dis 1997, 10:103.
145. Iversson LB, da Rosa AP, Rosa MD, et al. [Human infection by hantavirus in southern and southeastern Brazil]. Rev Associacao Medica Brasileira 1994, 40:85-92.
146. Lopez N, Padula P, Rossi C, et al. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 1996, 220:223-226.
147. Parisi M, Enria E, Padula P, et al. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Medicina (B Aires) 1996, 56:1.
148. Khan AS, Gaviria M, Rollin PE, et al. Hantavirus pulmonary syndrome in Florida: Association with the newly identified Black Creek Canal virus. Am J Med 1996, 100:46-48.
149. Khan AS, Spiropoulou CF, Morzunov S, et al. Fatal illness associated with a new hantavirus in Louisiana. J Med Virol 1995, 46:281-286.
150. Hjelle B, Goade D, Torres-Martinez N, et al. Hantavirus pulmonary syndrome, renal insufficiency, and myositis associated with infection by Bayou hantavirus. Clin Infect Dis 1996, 23:495-500.
151. Hantavirus pulmonary syndrome-Chile, 1997. MMWR 1997, 46:949-951.
152. Enria DA, Briggler AM, Pini N, et al. Clinical manifestations of new world hantaviruses [Review]. Curr Topmicrobiol Immunol 2001, 256:117-134.
153. Simonsen L, Dalton MJ, Breiman RF, et al. Evaluation of the magnitude of the 1993 hantavirus outbreak in the southwestern United States. J Infect Dis 1995, 172:729-733.
154. Zeitz PS, Graber JM, Voorhes RA, et al. Assessment of occupational risk for hantavirus infection in Arizona and New Mexico. J Occup Environ Med 1997, 39:463-467.
155. Forslund T, Saltevo J, Anttinen J, et al. Complications of nephropathia epidemica: three cases. J Intern Med 1992, 232:87-90.
156. Zaki SR, Peters CJ Viral hemorrhagic fevers. The Pathology of Infectious Diseases 1997, 347. Appleton & Lange, Norwalk, Conn. D.H. Connor, F.W. Chandler, D.A. Schwartz (Eds.).
157. Niklasson B, Kjelsson T Detection of nephropathia epidemica (Puumala virus)-specific immunoglobulin M by enzyme-linked immunosorbent assay. J Clin Microbiol 1988, 26:1519-1523.
158. LeDuc JW, Ksiazek TG, Rossi C, et al. A retrospective analysis of sera collected by the Hemorrhagic Fever Commission during the Korean Conflict. J Infect Dis 1990, 162:1182-1184.
159. Lewis RM, Lee HW, See AF, et al. Changes in populations of immune effector cells during the course of haemorrhagic fever with renal syndrome. Trans R Soc Trop Med Hyg 1991, 85:282-286.
160. Peters CJ Viral hemorrhagic fever. Viral Pathogenesis 1997, 779. Lippincott-Raven, Philadelphia. N. Nathanson, R. Ahmed, F. Gonzalez-Scarano (Eds.).
161. Krakauer T, LeDuc JW, Morrill JC, et al. Serum levels of alpha and gamma interferons in hemorrhagic fever with renal syndrome. Viral Immunol 1994, 7:97-101.
162. Linderholm M, Ahlm C, Settergren B, et al. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis 1996, 173:38-43.
163. Groeneveld PH, Colson P, Kwappenberg KM, et al. Increased production of nitric oxide in patients infected with the European variant of hantavirus. Scand J Infect Dis 1995, 27:453-456.
164. Kim S, Kang ET, Kim YG, et al. Localization of Hantaan viral envelope glycoproteins by monoclonal antibodies in renal tissues from patients with Korean hemorrhagic fever. Am J Clin Pathol 1993, 100:398-403.
165. Koster FT, Simpson SQ, Feddersen KM, et al: Immunopathogenesis of hantavirus pulmonary syndrome (HPS): Role of the T cell. In US-Japan Cooperative Medical Sciences Program. Abstracts of the 29th Joint Viral Diseases Panels Meeting, Santa Fe, New Mexico, 1996.
166. Linderholm M, Billstrom A, Settergren B, et al. Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection 1992, 20:263-266.
167. Linderholm M, Sandstrom T, Rinnstrom O, et al. Impaired pulmonary function in patients with hemorrhagic fever with renal syndrome. Clin Infect Dis 1997, 25:1084-1089.
168. Kim D Clinical analysis of 111 fatal cases of epidemic hemorrhagic fever. Am J Med 1965, 39:218-220.
169. Bruno P, Hassell LH, Quan J, et al. Hemorrhagic fever with renal syndrome imported to Hawaii from West Germany. Am J Med 1990, 89:232-234.
170. Clement J, Colson P, McKenna P Hantavirus pulmonary syndrome in New England and Europe. [Comment]. N Engl J Med 1994, 331:545-546. author reply 331: 547-548, 1994.
171. Plyusnin A, Horling J, Kanenva M, et al. Puumala hantavirus genome in patients with nephropathia epidemica: Correlation of PCR positivity with HLA haplotype and link to viral sequences in local rodents. J Clin Microbiol 1997, 35:1090-1096.
172. Khan AS, Ksiazek TG, Peters CJ, et al. Viral hemorrhagic fevers. Semin Pediatr Infect Dis 1997, 8:64.
173. Ivanov AP, Tkachenko EA, Petrov VA, et al. Enzyme immunoassay for the detection of virus specific IgG and IgM antibody in patients with haemorrhagic fever with renal syndrome. Arch Virol 1988, 100:1-7.
174. Feldmann H, Sanchez A, Monrunov S, et al. Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res 1993, 30:351-367.
175. Hjelle B, Jenison S, Torrez-Martinez N, et al. Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis. J Clin Microbiol 1997, 35:600-608.
176. Wells RM, Sosa Estani S, Yadon ZE, et al. An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia. Emerg Infect Dis 1997, 3:171-174.
177. Jenison S, Yamada T, Morris C, et al. Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome. J Virol 1994, 68:3000-3006.
178. Elgh F, Wadell G, Juto P Comparison of the kinetics of Puumala virus specific IgM and IgG antibody responses in nephropathia epidemica as measured by a recombinant antigen-based enzyme-linked immunosorbent assay and an immunofluorescence test. J Med Virol 1995, 45:146-150.
179. Duermeyer W, Wielaard F, van der Veen J A new principle for the detection of specific IgM antibodies applied in an ELISA for hepatitis A. J Med Virol 1979, 4:25-32.
180. Chu YK, Jennings G, Schmaljohn A, et al. Cross-neutralization of hantaviruses with immune sera from experimentally infected animals and from hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome patients. J Infect Dis 1995, 172:1581-1584.
181. Lundkvist A, Hukic M, Horling J, et al. Puumala and Dobrava viruses cause hemorrhagic fever with renal syndrome in Bosnia-Herzegovina: Evidence of highly cross-neutralizing antibody responses in early patient sera. J Med Virol 1997, 53:51-59.
182. Wang M, Rossi C, Schmaljohn CS Expression of non-conserved regions of the S genome segments of three hantaviruses: evaluation of the expressed polypeptides for diagnosis of haemorrhagic fever with renal syndrome. J Gen Virol 1993, 74:1115-1124.
183. Tsai TF, Bauer SP, Sasso DR, et al. Serological and virological evidence of a Hantaan virus-related enzootic in the United States. J Infect Dis 1985, 152:126-136.
184. Nichol ST, Ksiazek TG, Peters CJ Hantavirus pulmonary syndrome and newly described hantaviruses in the United States. The Bunyaviridae 1996, 269. Plenum Press, New York. R.M. Eliott (Ed.).
185. Hjelle B, Spiropoulou CF, Torres-Martinez N, et al. Detection of Muerto Canyon virus RNA in peripheral blood mononuclear cells from patients with hantavirus pulmonary syndrome. J Infect Dis 1994, 170:1013-1017.
186. Zaki SR, Khan AS, Goodman RA, et al. Retrospective diagnosis of hantavirus pulmonary syndrome, 1978-1993: Implications for emerging infectious diseases. Arch Pathol Lab Med 1996, 120:134-139.
187. Schwarz TF, Zaki SR, Morzunov S, et al. Detection and sequence confirmation of Sin Nombre virus RNA in paraffin-embedded human tissues using one-step RT-PCR. J Virol Methods 1995, 51:349-356.
188. Huggins JW, Hsiang CM, Cosgriff TM, et al. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis 1991, 164:1119-1127.
189. Sayer WJ, Entwhisle G, Uyeno BT, et al. Cortisone therapy of early epidemic hemorrhagic fever: A preliminary report. Ann Intern Med 1955, 42:839-851.
190. Chapman LE, Mertz GJ, Peters CJ, et al. Intravenous ribavirin for hantavirus pulmonary syndrome: Safety and tolerance during 1 year of open-label experience. Ribavirin Study Group. Antiviral Ther 1999, 4:211-219.
191. Hantavirus pulmonary syndrome- United States: updated recommendations for risk reduction. MMWR 2002, 51:1-13. Centers for Disease Control.
192. Glass GE, Johnson JS, Hodenbach GA, et al. Experimental evaluation of rodent exclusion methods to reduce hantavirus transmission to humans in rural housing. Am J Trop Med Hyg 1997, 56:359-364.
193. Hopkins AS, Whitetail-Eagle J, Corneli AL, et al. Experimental evaluation of rodent exclusion methods to reduce hantavirus transmission to residents in a Native American community in New Mexico. Vector Borne Zoonotic Dis 2002, 2:61-68.
194. Douglass RJ, Kuenzi AJ, Williams CY, et al. Removing deer mice from buildings and the risk for human exposure to Sin Nombre virus. Emerg Infect Dis 2003, 9:390-392.
195. Lee HW, Baek LJ, Seyons YW, et al. Physiochemical properties of Hantaan virus. 2. The effect of temperature and pH on infectivity of Hantaan virus. J Korean Soc Virology 1983, 13:23-28.
196. Schmaljohn J, Huggins JW Laboratory and field safety. Manual of Hemorrhagic Fever with Renal Syndrome and Hantavirus Pulmonary Syndrome 1999, 192-198. WHO Collaborating Center for Virus Reference and Research (Hantaviruses), Asan Institute for Life Sciences, Seoul. H.W. Lee, C.H. Calisher, C. Schmaljohn (Eds.).
197. Vitek CR, Ksiazek TG, Peters CJ, et al. Evidence against infection with hantaviruses among forest and park workers in the southwestern United States. Clin Infect Dis 1996, 23:283-285.
198. Wells RM, Young J, Williams RJ, et al. Hantavirus transmission in the United States. Emerg Infect Dis 1997, 3:361-365.
199. Yang L, Lloyd ES: Getting the message out: Use of private-sector partner to increase public awareness of hantavirus disease prevention. In Abstracts of the 124th Annual Meeting of the American Public Health Association, New York, 1996.
200. Hooper JW, Larsen T, Custer DM, et al. A lethal disease model for hantavirus pulmonary syndrome. Virology 2001, 289:6-14.
201. Custer DM, Thompson E, Schmaljohn CS, et al. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J Virol 2003, 77:9894-9905.
202. Arikawa J, Yao JS, Yoshimatsu K, et al. Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies. Arch Virol 1992, 126:271-281.
203. Asada H, Balachandra K, Tamura M, et al. Cross-reactive immunity among different serotypes of virus causing haemorrhagic fever with renal syndrome. J Gen Virol 1989, 70:819-825.
204. Schmaljohn CS, Chu YK, Schmaljohn AL, et al. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants. J Virol 1990, 64:3162-3170.
205. Schmaljohn C Prospects for vaccines to control viruses in the family Bunyaviridae. Rev Med Virol 1994, 85:240-251.
206. Monroe MC, Morzunov SP, Johnson AM, et al. Genetic diversity and distribution of Peromyscus-borne hantaviruses in North America. Emerg Infect Dis 1999, 5:314. [Erratum in].
207. Emerg Infect Dis 1999, 5:75-86.
208. Ennis FA, Cruz J, Spiropoulou C, et al. Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. Virology 1997, 238:380-390.
209. Lee H, Ahn C, Song JW, et al. Field trial of an inactivated vaccine against hemorrhagic fever with renal syndrome in humans. Arch Virol 1990, (suppl 1):35.
210. Chen H Cooperative Group on the ninth-five years National Medical Scientific Study 96-906-03-13. Evaluation on the efficacy of vaccines against HFRS and study on their antibody dependent immunization enhancement and immunological strategy. Chung Hua Yu Fang I Hsueh Tsa Chih (Chin J Prevent Med) 1997, 8:321.
211. McClain DJ, Summers PL, Harrison SA, et al. Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine. J Med Virol 2000, 60:77-85.